Snai1 (Snail) and Snai2 (Slug), the two main members of Snail family factors, are important mediators of epithelial-mesenchymal transitions and involved in tumor progression. We recently reported that Snai1 plays a major role in tumor growth, invasion and metastasis, but the contribution of Snai2 to tumorigenesis is not yet well understood. To approach this question we have silenced Snai2 and/or Snai1 by stable RNA interference in two independent mouse skin carcinoma (HaCa4 and CarB) cell lines. We demonstrate that Snai2 knockdown has a milder effect, but collaborates with Snai1 silencing in reduction of tumor growth potential of either carcinoma cell line when injected into nude mice. Importantly, Snai1 or Snai2 silencing dramatically influences the metastatic ability of squamous carcinoma HaCa4 cells, inducing a strong reduction in liver and lung distant metastasis. However, only Snai1 knockdown has an effective action on invasiveness and fully abolishes tumor cell dissemination into the spleen. These results demonstrate that Snai1 and Snai2 collaborate on primary tumor growth and specifically contribute to site-specific metastasis of HaCa4 cells. These data also indicate that Snai1 is the major regulator of local invasion, supporting a hierarchical participation of both factors in the metastatic process.
Introduction
Despite the enormous knowledge accumulated in the past decades on the mechanisms of tumor generation, very little is still known about the molecular mechanisms governing metastatic dissemination (Mehlen and Puisieux, 2006) . Local invasion is presently considered as the leading event for carcinoma metastasis (Christofori, 2006; Gupta and Massague, 2006) . During the invasive process, tumor cells lose their cell-cell adhesion properties and undergo profound changes in their phenotype known as epithelial-mesenchymal transition (EMT), a process reminiscent of developmental EMT (Nieto, 2002; Thiery, 2002) . Downregulation of E-cadherin is a hallmark of EMT and occurs frequently during carcinoma progression (Birchmeier and Behrens, 1994; Christofori and Semb, 1999; Thiery, 2002) . Transcriptional repression mechanisms of E-cadherin have been intensively investigated in the last years and several transcription factors characterized as E-cadherin repressors (reviewed in Peinado et al., 2007) . Among them, two members of the Snail superfamily, Snai1 (Snail; Batlle et al., 2000; Cano et al., 2000) and Snai2 (Slug; Hajra et al., 2002; Bolos et al., 2003) are presently considered key regulators of EMT (Nieto, 2002) . Although the function of Snai1 and Snai2 can be interchangeable in different species (Barrallo-Gimeno and Nieto, 2005) , a distinct role for each factor is supported from analysis of knockout mice. While Snai1 null mice present early embryonic lethality (Carver et al., 2001) , Snai2 null mice are viable, undergoing a normal program of development (Jiang et al., 1998) . The specific contribution of Snai1 and Snai2 to tumor progression is still poorly defined. Recent studies on Snail factors indicate that either Snai1 and/or Snai2 can be expressed in different carcinomas, including breast, ovarian, colon and squamous cell carcinomas, sometimes associated to invasion, metastasis and/or poor prognosis (Peinado et al., 2007) . Previous studies on human breast carcinoma cells also suggested a differential involvement of Snai1 and Snai2 in E-cadherin repression or specific invasion patterns (Hajra et al., 2002; Come et al., 2006) . We recently described an important role for Snai1 in tumor growth, differentiation and invasion of mouse skin (Olmeda et al., 2007a) , and in lymph node metastasis of human breast carcinoma cells (Olmeda et al, 2007b) . Now, we have investigated the interplay between Snai1 and Snai2 in tumorigenesis targeting each factor by stable RNA interference in two mouse skin carcinoma cell lines, analysing their effect in in vitro invasion, and tumorigenic and metastatic behaviour into nude mice. Our results indicate that Snai1 and Snai2 collaborate on in vivo tumor growth and induction of lung and liver distant metastasis. Importantly, Snai1 is determinant for local invasion and tumor cell dissemination into spleen. Together, these data support an interplay and hierarchical participation of Snai1 and Snai2 during tumor progression.
Results

shSnai2 inhibits Snai2 expression without affecting Snai1
We have previously reported that Snai2 represses the proximal E-cadherin promoter inducing a full EMT process (Bolos et al., 2003) . We first used MDCK-Snai2 cells to prove that siRNA against Snai2 abrogates its transcriptional repression, by choosing a 19-mer C-terminal Snai2 sequence not present in Snai1 mRNA of any species (Manzanares et al., 2001) , cloned into pTER-Zeo vector. The shSnai2 derepressed E-cadherin promoter in MDCK-Snai2 cells in a dose-dependent manner (Supplementary Figure S1A) . It also blocked the repressive action of Snai2-EGFP in MDCK cells. Importantly, the effect of shSnai2 is specific as it did not influence Snai1-EGFP mediated repression of E-cadherin promoter (Supplementary Figure S1B) . As previously reported, shSnai1 is specific for Snail1 repression (Supplementary Figure S1B ; Olmeda et al., 2007a) .
Interference of endogenous Snai2 in carcinoma cells affects EMT markers and cooperates with Snai1 silencing in decreased invasiveness The effectiveness of shSnai2 to block endogenous Snai2 expression was analysed in two mouse epidermal carcinoma cell lines, derived from mouse squamous cell carcinoma (HaCa4) and spindle cell carcinoma (CarB), extensively characterized previously as E-cadherin deficient, expressing high levels of Snai1 and Snai2, and showing highly invasive, tumorigenic and metastatic behaviour (Navarro et al., 1991; Llorens et al., 1998; Cano et al., 2000) . We have recently reported that endogenous Snai1 silencing in HaCa4 and CarB cells leads to decreased expression of mesenchymal markers and invasiveness (Olmeda et al., 2007a) . To answer whether Snai2 could collaborate with Snai1 in the phenotype and tumorigenic behaviour of both carcinoma cell lines, the shSnai2 vector was stably transfected in HaCa4 and CarB cells in the absence or presence of shSnai1. Stable clones (5-10) were isolated and characterized from each cell line and transfection (named HaCa4-shSnai2 or CarB-shSnai2 for shSnai2, and HSS and CSS for shSnai1/shSnai2 double interference); two representative examples of each type are shown. Two selected clones of the recently described HaCa4-shSnai1 and CarB-shSnai1 cells (Olmeda et al., 2007a) were included. Cells stably transfected with shEGFP (HaCa4-shEGFP and CarB-shEGFP) were used as negative controls. Reverse transcription (RT)-PCR and immunoblot analyses showed the effectiveness of Snai2 and/or Snai1 silencing (Figures 1a and b , and data not shown), demonstrating the almost total blockade of Snai2 and/ or Snai1 expression. The specificity of the individual interference was also evidenced; no significant changes in endogenous Snai1 or Snai2 levels were detected in the shSnai2-and shSnai1-derived clones (Figures 1a and b) . Expression of EMT markers was then analysed. Reexpression of E-cadherin transcripts was detected in HaCa4 cells after double interference (HSS-C1/C7) to similar levels obtained after Snai1 silencing, but not in HaCa4-shSnai2 cells (Figure 1a , left), indicating that Snai1 expression is sufficient to repress E-cadherin in HaCa4 cells. No expression of E-cadherin protein could be detected in cultures of HaCa4-derived clones (Olmeda et al., 2007a ; data not shown). Induction of E-cadherin expression could not be detected in CarBderived clones (Figure 1a, right) . The absence of genetic alterations in the E-cadherin locus in CarB cells (Navarro et al., 1991; Rodrigo et al., 1999) , suggests that additional repressors or epigenetic mechanisms affect E-cadherin expression in this cell line; indeed, hypermethylation of E-cadherin promoter was detected in CarB cells (Fraga et al., 2004) . Expression of the mesenchymal markers vimentin and fibronectin, was not affected by Snai2 silencing but was significantly decreased (50-60%) in double interfered CarB cells (CSS-D5/D10; Figure 1c , right), similar to CarBshSnai1 cells (Olmeda et al., 2007a) . Vimentin and fibronectin expression was moderately reduced in double interfered HaCa4 (HSS-C1/C7; 30-40%), but not affected in HaCa4-shSnai2 (Figure 1c , left) or HaCa4-shSnai1 cells (Olmeda et al., 2007a) . These results, suggest that Snai1 and Snai2 can cooperate in the expression of mesenchymal markers in a cell context dependent manner. Silencing of Snai1 and/or Snai2 induces subtle changes in the epithelioid phenotype of HaCa4 cells that grow in compact epithelial-like islands at low cell density; however, at confluence the phenotype was not influenced (Supplementary Figure S2A , left panels). No changes in the spindle phenotype of CarB cells was detected after Snai1 and/or Snai2 knockdown at any density (Supplementary Figure S2B) . In agreement with the morphological phenotype, Snai1 and/or Snai2 silencing did not modify the organization of the F-actin and microtubule cytoskeleton of either cell type (Supplementary Figures S2A and B) .
We next analysed the effect of Snai2 and/or Snai1 silencing on MMP-9. Double interfered HaCa4 (HSS-C1/C7) and CarB (CSS-D5/D10) cells showed moderate to strong decrease in secreted MMP-9 activity (40-60%), to levels similar to those obtained after Snai1 silencing (Figure 2a) . Interestingly, no changes or even increased MMP-9 activity was detected after Snai2 silencing in HaCa4 or CarB cells, respectively (Figure 2a) . These results support a main role for Snai1 in the regulation of MMP-9, in agreement with the reported Snai1 upregulation of MMP9 promoter (Jorda et al., 2005) . In contrast, MMP-2 activity was not significantly affected by Snai1 and/or Snai2 silencing, although a slight increase was detected over controls in the HaCa4 system (Figure 2a, left) . Finally, to analyse the biological effect of Snai1 and Snai2 silencing in invasion, transwell assays were performed. Snai2
Snai1 and Snai2 silencing and metastasis inhibition D Olmeda et al silencing induced a slight but significant reduction in the in vitro invasiveness of CarB cells (Figure 2b , right), whereas it did not affect invasion of HaCa4 cells (Figure 2b, left) . In contrast, Snai1 silencing provokes a marked decrease in invasion in both cell types ( Figure 2b ). Importantly, further reduction was observed after Snai1/Snai2 silencing (Figure 2b ), suggesting the active collaboration of both factors in induction of a fully invasive phenotype in HaCa4 and CarB cells.
Snai1 and Snai2 interference dramatically decreases tumor growth potential
Snai1 silencing in HaCa4 and CarB cells induces a strong reduction in xenograft growth rate and leads to more differentiated tumor phenotype (Olmeda et al., 2007a) . To analyse if Snai1 and Snai2 collaborate on tumor growth and/or differentiation potential, two independent clones from each transfection type were orthotopically (subcutaneously) injected (1 Â 10 6 cells per site) into nude mice, in parallel with the corresponding parental and control cells. All clones formed primary tumors at all injection sites. Tumors induced by HaCa4-shSnai2 and CarB-shSnai2 cells grew at lower rates than those induced by parental or control cells; about 30-40% reduction in tumor volume was observed in HaCa4-shSnai2 and CarB-shSnai2 xenografts at 14 and 17 days post-injection (d.p.i.), respectively ( Figure 3a) . Snai1 silencing induced a much stronger effect, particularly in HaCa4 cells, where a 90% reduction was observed 14 d.p.i. (Figure 3a , left). Notably, double Snai1/Snai2 interference induced a dramatic 95% tumor volume reduction of CarB-SS and further reduced, up to 99%, the tumor volume of HaCa4-SS xenografts at 17 and 14 d.p.i., respectively (Figure 3a) . The strong reduction in the tumor growth potential induced by 
C13 C14
HaCa4 shSnai2
α-Tub-α-Tub- Figure S3) . A significant effect of Snai2 silencing was also detected in low cell injections in CarBshSnai2 xenografts. Those experiments also confirmed the strong collaborative effect of Snai1 and Snai2 in the tumorigenicity of HaCa4 cells, as the incidence of tumors decreased up to 50% for HaCa4-SS cells (Supplementary Table S1 ), suggesting a role of Snai1/ Snai2 in tumor cell maintenance. Together, these results indicate that Snai2 influences the tumorigenic behaviour of CarB cells, and collaborates with Snai1 on tumor growth potential of both HaCa4 and CarB cells.
RT-PCR and immunoblot analysis of xenografts indicated that Snai1 and/or Snai2 remained silenced in all tumors derived from shSnai1 and/or shSnai2 clones from HaCa4 or CarB cells (Figures 3b and c) . Interestingly, re-expression of E-cadherin transcripts inside tumors was detected in those cases that maintained Snai1/Snai2 silenced. Modest E-cadherin re-expression was also detected in HaCa4-shSnai2 xenografts ( Figure 3b) and confirmed at protein level in HaCa4-shSnai1-and/or HaCa4-shSnai2-derived tumors, and CarB-SS xenografts by immunoblot ( Figure 3c ) and immunohistochemical analyses (see below). These results, therefore, indicate that Snai1/ Snai2 silencing contributes to effectively de-repress E-cadherin in in vivo contexts.
Histological and immunofluorescence analysis of the xenografts confirmed the biological effect of Snai2 and/ or Snai1 blockade. Figures 5A, a-f ). In agreement with the histological pattern, immunohistochemical analyses showed re-expression of E-cadherin at cell-cell contacts in HaCa4-shSnai2 and HSS-C1 xenografts, particularly at the most differentiated regions ( Figures 4A, h and i ). E-cadherin was also detected in CSS-D5, in a diffuse pattern ( Figure 5A, i) , in contrast to the total lack of E-cadherin in CarB-shEGFP and CarB-shSnai2 xenografts ( Figures 5A, g and h) . Cyclin D1 expression was markedly decreased in HaCa4-shSnai2 and HSS-C1 xenografts regarding control Figure S4) and no signs of senescence were detected in any cell type in culture (not shown). Immunofluorescence analysis of MMP-9 indicated strong reduction in HSS-C1 ( Figure  4A , o) and CSS-D5 ( Figure 5A , o) xenografts compared to controls. Interestingly, significant reduction of MMP-9 was also detected in CarB-shSnail2 xenografts ( Figure  5A , n), suggesting a differential regulation of MMP-9 between in vivo and in vitro situations. Quantitative realtime PCR (qRT-PCR) confirmed the reduction of MMP-9 transcripts in HSS-C1/C7 ( Figure 4B ), CSS-D5/D10 and CarB-shSnai2-C18/C19 tumors ( Figure 5B ). Moreover, a strong reduction in transcript levels of fibronectin and vimentin was detected in HSS-C1/C7 ( Figure 4B ), CSS-D5/D10 and CarB-shSnai2 xenografts ( Figure 5B ), further confirming the induction of a more differentiated, less invasive tumor phenotype after Snai1 and/or Snai2 silencing. Finally, CD31 staining of the central region of HSS-C1/C7 and CSS-D5/D10 xenografts showed a dramatic decrease in angiogenic potential regarding tumors induced by control and shSnai2-derived cells ( Figures 4A and 5A , compare panel r to p and q). Together, these data suggest that inhibition of tumor growth induced by Snai2 and/or Snai1 silencing can be mediated by a combination of action on the proliferation, differentiation/angiogenic properties of HaCa4 and CarB cells in in vivo contexts.
Snai1 and Snai2 interference dramatically reduces the metastatic capability of HaCa4 carcinoma cells
We next analysed the effect of Snai1 or Snai2 silencing on the metastatic properties of HaCa4 cells. Spontaneous metastasis assays were performed in HaCa4-shSnai1-C11/C33 and HaCa4-shSnai2-C13/C14 clones, in parallel with control HaCa4 and HaCa4-shEGFP cells. After orthotopic subcutaneous injection, tumors were surgically removed when they reached a volume of 0.4 cm 3 and mice were allowed to live until they become moribund. During the process, the presence of lung metastasis was analysed by non-invasive magnetic resonance imaging (MRI). Mice injected with HaCa4-shSnai1-C11/C33 cells survive longer (nearly two-fold increase in the post-injection survival period) than HaCa4-shSnai2-C13/C14 and HaCa4-shEGFP injected mice (Table 1) . Parental HaCa4 and control HaCa4-shEGFP cells metastasized into lung, liver and spleen ( Figure 6 ; Table 2 ) with multiple metastatic nodes in almost all injected mice at 25-35 d.p.i. Noteworthy, a strong reduction in the metastatic ability of HaCa4-shSnai1-C11/C33 cells was detected ( Figure 6 ; Table 2 ). Macrometastasis to different organs was observed only in 25% of HaCa4-shSnai1-C11-injected mice, and not in HaCa4-shSnai1-C33-injected mice. A few micrometastasis foci were detected in liver and spleen of mice injected with HaCa4-shSnai1-C11/C33 cells (Table 2) . Interestingly, although Snai2 interference in HaCa4 cells did not strongly affect tumor latency and mice survival (Table 1 , Figure 3a) , a total block of liver metastasis and strong (60-80%) reduction in lung metastasis was found, but no effect on spleen metastasis was detected ( Figure 6 and Table 2 ). Taken together, these results indicate a strong influence of Snai1 and Snai2 in the generation of liver and lung metastasis and a more specific effect of Snai1 in spleen dissemination of HaCa4 cells.
Discussion
The Snail family factors, Snai1 and Snai2, are key regulators of EMT (Nieto, 2002) and important players of tumor invasion. In addition, they participate in other meaningful biological processes, like induction of cell movement and survival, also potentially contributing to other aspects of tumor progression (Barrallo-Gimeno and Nieto, 2005 ). An increasing number of studies have shown Snai1 and/or Snai2 expression in a variety of tumors (Peinado et al., 2007) , but whether they play specific or redundant functions in tumor progression remains largely unknown. We have started to approach this issue targeting Snai1 and/or Snai2 by RNA interference in mouse skin carcinoma cell lines HaCa4 and CarB. Our recent studies indicated that Snai1 silencing in both cell lines induces a more differentiated, less invasive phenotype with a significant reduction in their tumorigenic capacity (Olmeda et al., 2007a) . SNAI1 knockdown also dramatically affects tumor Snai1 and Snai2 silencing and metastasis inhibition D Olmeda et al growth and lymph node metastasis of human breast carcinoma cells (Olmeda et al., 2007b) . We now report that Snai2 cooperates with Snai1 in tumor growth potential of HaCa4 and CarB and in the generation of lung and liver metastasis. An essential role for Snai1 in local invasion and tumor cell dissemination to spleen is also inferred from our present results.
In contrast to the effect observed after Snai1 silencing, Snai2 did not significantly modify the expression of E-cadherin or mesenchymal markers in HaCa4 or CarB cells when growing in culture, indicating that Snai1 is necessary and sufficient to repress E-cadherin and to maintain expression of mesenchymal markers in vitro. Vimentin/fibronectin upregulation by Snail factors are largely unknown but might involve indirect Snai1 and Snai2 silencing and metastasis inhibition D Olmeda et al transcriptional regulation (Guaita et al., 2002) , as has been reported for Snai1 induction of MMP9 and ID1 genes (Jorda et al., 2005 (Jorda et al., , 2007 . The apparent higher potential of Snai1 over Snai2 in E-cadherin repression could be partly explained, by the higher affinity of Snai1 to the E-boxes of the E-cadherin promoter over Snai2 detected in vitro (Bolos et al., 2003) and supported by the expression of E-cadherin in Snai1À/Snai2 þ mouse keratinocyte cell lines (Cano et al., 2000) . Nevertheless, re-expression of E-cadherin was detected in HaCa4-shSnai2 and in CarB-SS xenografts, suggesting that Snai2 can also contribute to the full repression of E-cadherin in certain in vivo contexts. Apart from E-cadherin regulation, acquisition of well-differentiated squamous carcinoma phenotype seems to depend mainly on Snai1 silencing ( Figure 4A ; Olmeda et al., 2007a) , supporting that Snai1 predominates over Snai2 in the maintenance of poorly differentiated squamous cell carcinoma phenotype. Importantly, Snai1 expression is determinant for invasiveness, as Snai1 silencing significantly decreases in vitro invasion of HaCa4 and CarB cells, whereas Snai2 silencing only modestly affect CarB cells invasiveness. However, Snai2 appears to collaborate in the control of tumor invasion, as further reduction of invasion was observed in HaCa4 and CarB cells interfered for Snai1/Snai2 (Figure 2b) . The collaboration of Snai2 in invasion appears to be independent of MMP9/MMP2 expression/activity suggesting that other methaloproteinases and/or proinvasive molecules could be regulated by Snai2. Nevertheless, a significant decrease of MMP9 and mesenchymal markers was detected in CarB-shSnai2 xenografts (Figure 5 ), suggesting that Snai2 can control certain aspects of tumor invasion/differentiation in determined tumor contexts. These observations are also compatible with the differential roles proposed for Snai1 and Snai2 factors in individual vs collective tumor invasion, or distinct anatomic dissemination of breast and ovarian tumors (Elloul et al., 2005 (Elloul et al., , 2006 Come et al., 2006) , and for Snai2 in wound healing migration (Savagner et al., 2005) .
The tumorigenic and spontaneous metastasis assays performed after Snai2 and/or Snai1 silencing have added new important insights into the in vivo role of both factors. As previously reported (Olmeda et al., 2007a) , Snai1 silencing dramatically reduces the tumor growth rate of HaCa4 and CarB cells, whereas Snai2 silencing has a lower effect on both kinds of xenografts (Figure 3a) . Importantly, Snai1/Snai2 silencing further reduces tumor growth rate in mouse skin carcinoma cells. Noteworthy, the reduction in tumor growth potential after Snai1/Snai2 silencing was associated with decreased tumoral MMP9 expression and reduced angiogenesis. These results support that Snai1 and Snai2 collaborate in induction of tumor growth. Furthermore, Snai1 and Snai2 actively participate in the generation of distant metastasis. Snail1 silencing almost completely abrogated the capacity of HaCa4 cells to produce distant metastasis, whereas Snai2 silencing reduced liver, and to a lower extent, lung metastasis, but did not affect spleen metastasis. These differences in Snai1 and Snai2 action could reflect, at least in part, the different invasion potential induced by both factors. As such, the dramatic suppression of distant metastasis induced after Snai1 silencing could mainly be attributed to the strong blockade of local invasion, the first step of tumor metastasis. The lack of effect of Snai2 silencing in invasiveness and spleen metastasis also indicates that expression of Snai1 is sufficient to promote both local invasion and tumor cell dissemination into spleen. These results are also in line with the recent observation that SNAI1 expression is a requisite for lymph node metastasis of human breast carcinoma cells (Olmeda et al., 2007b) . On the other hand, the strong influence of Snai2 silencing in reduction of liver and lung metastasis could be related to the cell survival properties (Inoue et al., 2002; Perez-Losada et al., 2003; Kajita et al., 2004) or the specific migration properties conferred by Snai2 (Barrallo-Gimeno and Nieto, 2005; Elloul et al., 2005; Come et al., 2006) that could restrain effective lung and liver colonization in its absence.
Taken together, the results presented here support that Snai1 and Snai2 collaborate on tumor growth potential and induction of distant metastasis, with complementary rather than redundant roles in tumor progression. Our results indicate that Snai1 is necessary for the onset of metastasis favouring local invasion, whereas Snai2 is additionally required for the establishment of distant site-specific lung and liver metastasis, supporting a sequential, hierarchical action of Snail factors during tumor progression of mouse skin carcinomas. Further studies are required to determine the collaboration of Snail factors in other tumor types.
Materials and methods
Generation of expression vectors and stable cell lines
Mouse CarB, HaCa4 and derived cell lines were grown as described (Olmeda et al., 2007a) . The generation of shRNAs, against EGFP (shEGFP), or against mouse/human Snai1 (shSnai1) have been described (Jorda et al., 2005) . shRNA against mouse Snai2 (5 0 -gctccactccactctcctt-3 0 ; shSnai2) was generated by cloning into the pTER-Zeo vector. The different vectors were transfected using lipofectamine (Gibco BRL, San Diego, CA, USA), and stable transfectants obtained by selection with the appropriate antibiotic (1 mg/ml of puromycin and/or 100 mg/ml zeocyn) during 2-4 weeks. Clones (10-20) were isolated after each shRNA transfection and individually characterized, or collected as pooled clones in control transfections. The origin and characterization of HaCa4 and CarB cells has been previously described (Navarro et al., 1991; Llorens et al., 1998) .
RT-PCR, quantitative RT-PCR and promoter analysis
Total RNA was isolated from the different cell lines and tumors, and RT-PCR carried out as described (Peinado et al., 2005) . For qRT-PCR, cDNA was synthesized using High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). Primers and PCR conditions were as described (Olmeda et al., 2007a) . The proximal mouse E-cadherin-Luc (À178 to þ 92) promoter was used as described (Olmeda et al., 2007a) . 
